Basics Beam Therapeutics Inc. IPO Date: February 6, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.63B Activated in VL: True Average Daily Range Avg Daily Range: $1.60 | 3.50% Avg Daily Range (30 D): $0.40 | 2.19% Avg Daily Range (90 D): $0.82 | 3.72% Institutional Daily Volume Avg Daily Volume: .88M Avg Daily Volume (30 D): 1.66M Avg Daily Volume (90 D): 1.83M Trade Size Avg Trade Size (Sh.): 58 Avg Trade Size (Sh.) (30 D): 66 Avg Trade Size (Sh.) (90 D): 69 Institutional Trades Total Inst.Trades: 2,935 Avg Inst. Trade: $3.15M Avg Inst. Trade (30 D): $2.73M Avg Inst. Trade (90 D): $2.84M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.87M Avg Closing Trade (30 D): $3.82M Avg Closing Trade (90 D): $5.03M Avg Closing Volume: 130.39K     News May 29, 2025 @ 8:01 PM Beam Therapeutics Announces U.S. FDA Orphan Drug D... Source: N/A May 6, 2025 @ 9:05 PM Why Beam Therapeutics Stock Tanked on Tuesday Source: Eric Volkman Mar 10, 2025 @ 10:01 AM Beam Therapeutics Announces Pricing of Underwritte... Source: N/A Feb 24, 2025 @ 12:00 PM Beam Therapeutics to Participate in Upcoming March... Source: N/A Jan 30, 2025 @ 12:00 PM Beam Therapeutics to Participate in Guggenheim SMI... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-4.61 $-1.24 $-1.09 Diluted EPS $-4.61 $-1.24 $-1.09 Revenue $ 63.58M $ 7.47M $ 30.07M Gross Profit $ $ $ Net Income / Loss $ -387.34M $ -109.27M $ -90.35M Operating Income / Loss $ -430.72M $ -119.29M $ -100.04M Cost of Revenue $ $ $ Net Cash Flow $ 240.22M $ 244.41M $ 53.36M PE Ratio